These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34485909)

  • 1. Erratum to: Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed disease.
    Taslimi S; Ye VC; Zadeh G
    Neurooncol Adv; 2021; 3(1):vdab117. PubMed ID: 34485909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis.
    Alnahhas I; Alsawas M; Rayi A; Palmer JD; Raval R; Ong S; Giglio P; Murad MH; Puduvalli V
    Neurooncol Adv; 2021; 3(1):vdab095. PubMed ID: 34258581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum to: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis.
    Neurooncol Adv; 2022; 4(1):vdac125. PubMed ID: 35958979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum to: Targeting the TREM1-positive myeloid microenvironment in glioblastoma.
    Neurooncol Adv; 2023; 5(1):vdac189. PubMed ID: 36632568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: This is a corrigendum to: Kumthekar et al, A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac123, https://doi.org/10.1093/noajnl/vdac123.
    Neurooncol Adv; 2023; 5(1):vdad103. PubMed ID: 37664526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
    Song AJ; Ding K; Alnahhas I; Laperriere NJ; Perry J; Mason WP; Winch C; O'Callaghan CJ; Menten JJ; Brandes AA; Phillips C; Fay MF; Nishikawa R; Osoba D; Cairncross JG; Roa W; Wick W; Shi W
    Neurooncol Adv; 2022; 4(1):vdac011. PubMed ID: 35098127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials: Erratum.
    Medicine (Baltimore); 2017 Jun; 96(26):e7458. PubMed ID: 31305690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis: Erratum.
    Medicine (Baltimore); 2017 Jul; 96(30):e7724. PubMed ID: 31305702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Imaging biomarkers of glioblastoma treatment response: a systematic review and meta-analysis of recent machine learning studies.
    Frontiers Production Office
    Front Oncol; 2023; 13():1217461. PubMed ID: 37293592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Treatments for Shoulder Impingement Syndrome: A PRISMA Systematic Review and Network Meta-Analysis: Erratum.
    Medicine (Baltimore); 2016 Jun; 95(23):e96d5. PubMed ID: 31265590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Bridging the gap between research, policy, and practice: Lessons learned from academic-public partnerships in the CTSA network - CORRIGENDUM.
    Towfighi A; Orechwa AZ; Aragón TJ; Atkins M; Brown AF; Brown J; Carrasquillo O; Carson S; Fleisher P; Gustafson E; Herman DK; Inkelas M; Liu W; Meeker D; Mehta T; Miller DC; Paul-Brutus R; Potter MB; Rittner SS; Rodriguez B; Rusch D; Skinner A; Yee HF
    J Clin Transl Sci; 2020 Jul; 4(4):372. PubMed ID: 33244423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials.
    Saudi J Gastroenterol; 2017; 23(2):130. PubMed ID: 28361848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Medicine, Volume 95, Issue 23: Erratum.
    Medicine (Baltimore); 2016 Jul; 95(28):e0916. PubMed ID: 31265603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Medicine, Volume 95, Issue 24: Erratum.
    Medicine (Baltimore); 2016 Aug; 95(31):e5074. PubMed ID: 31265618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: The Effects Of Single Inhaler Triple Therapy Vs Single Inhaler Dual Therapy Or Separate Triple Therapy For The Management Of Chronic Obstructive Pulmonary Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2020; 15():155-156. PubMed ID: 32021154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum to: FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
    Sharaf R; Pavlick DC; Frampton GM; Cooper M; Jenkins J; Danziger N; Haberberger J; Alexander BM; Cloughesy T; Yong WH; Liau LM; Nghiemphu PL; Ji M; Lai A; Ramkissoon SH; Albacker LA
    Neurooncol Adv; 2021; 3(1):vdab059. PubMed ID: 34169283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
    Butt OH; Zhou AY; Huang J; Leidig WA; Silberstein AE; Chheda MG; Johanns TM; Ansstas G; Liu J; Talcott G; Nakiwala R; Shimony JS; Kim AH; Leuthardt EC; Tran DD; Campian JL
    Neurooncol Adv; 2022; 4(1):vdac042. PubMed ID: 35505674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum to: Dual-center validation of using magnetic resonance imaging radiomics to predict stereotactic radiosurgery outcomes.
    Neurooncol Adv; 2023; 5(1):vdad093. PubMed ID: 37576743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of antiangiogenic treatment for newly diagnosed glioblastoma: A protocol for systematic review and network meta-analysis.
    Li R; Li C; Cai Z; Li L; Wei L; Qian Z; Zhou D
    Medicine (Baltimore); 2020 May; 99(19):e20011. PubMed ID: 32384458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature.
    Neurooncol Adv; 2024; 6(1):vdae116. PubMed ID: 38978962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.